ArticleJAMA oncology2020

Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint Inhibitors-Reply.

Alexander M M Eggermont et al.PubMed ↗Publisher ↗

No numbers read from the abstract.